S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
IOVA · Iovance Biotherapeutics, Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Iovance Biotherapeutics Inc (IOVA)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$14.62
-0.25
(-1.68%)
● At close: October 21 at 4:00:00 PM EDT
$14.51
-0.11
(-0.75%)
Overnight:
8:48:44 PM EDT
DAY'S RANGE
$14.62
$14.60
$15.35
52-WEEK RANGE
$14.62
$1.76
$15.30
What's happening
- IOVA is down 1.68% today, trading at $14.62. — Live quote
- Volume today (646,566) is well below its 3-month average of 16,531,189. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.11 actual vs. $-0.13 estimated (+14.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 10
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (16 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
IOVA
+444.32%
vs S&P 500
+431.55%
1-YEAR RETURN
IOVA
+540.52%
vs S&P 500
+525.96%
6-MONTH RETURN
IOVA
+291.05%
3-MONTH RETURN
IOVA
+171.17%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.11
Est. $-0.13
BEAT +14.3%
2026-04-26 (Q1 2026)
$-0.19
Est. $-0.15
MISS -24.3%
2026-01-26 (Q4 2025)
$-0.18
Est. $-0.18
MISS -2.8%
2025-10-26 (Q3 2025)
$-0.25
Est. $-0.26
BEAT +5.0%
Valuation Measures & Ratios
Enterprise Value4$6.70B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)20.96
Price / Book72.52
EV4 / Revenue20.62
EV4 / EBITDA—
Profit Margin-89.09%
Operating Margin-92.72%
Return on Equity (ROE8)-40.51%
Return on Assets (ROA9)-31.65%
Avg Volume (3M)16,531,189
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $1.79B | $1.46B | — | $582.0M | $1.07B |
| P/E | -5.43 | -3.67 | — | -1.42 | -2.61 |
| Price/Sales | 6.00 | 5.88 | — | 2.93 | 7.67 |
| Price/Book | 2.43 | 2.02 | — | 0.83 | 1.40 |
| EV/Revenue | 5.63 | 5.09 | — | 2.26 | 6.44 |
| EV/EBITDA | -5.11 | -3.17 | — | — | — |
| ROE | -44.74% | -55.16% | — | -58.48% | -53.37% |
| ROA | -35.97% | -43.01% | — | -45.01% | -42.39% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short64,827,030
Change from Prior Settlement-25.60%
% of Float—
Days to Cover (Short Ratio)2.83
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 65.7% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +540.5%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -89.1%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on IOVA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $99.3M | $71.4M | $67.5M | $60.0M | $49.3M | $58.6M | $31.1M | $715.0K |
| Operating income | -$51.9M | -$81.0M | -$94.9M | -$113.8M | -$121.2M | -$89.1M | -$101.9M | -$117.7M |
| Net income | -$47.3M | -$79.0M | -$91.3M | -$111.7M | -$116.2M | -$83.5M | -$97.1M | -$113.0M |
| EPS (diluted) | $-0.11 | $-0.19 | — | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.42 |
| EPS (basic) | $-0.11 | $-0.19 | $-0.25 | $-0.33 | $-0.36 | $-0.28 | $-0.34 | $-0.42 |
| Operating margin | -$52 | -$113 | -$141 | -$190 | -$246 | -$152 | -$328 | -$16.5K |
| Net margin | -$48 | -$111 | -$135 | -$186 | -$236 | -$143 | -$312 | -$15.8K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $915.5M | $925.7M | $913.2M | $904.9M | $907.4M | $966.7M | $910.4M | $991.1M |
| Total liabilities | $179.5M | $203.9M | $214.6M | $202.7M | $208.9M | $198.9M | $200.0M | $217.7M |
| Stockholders' equity | $736.0M | $721.8M | $698.6M | $702.3M | $698.5M | $767.9M | $710.4M | $773.5M |
| Total current assets | $464.3M | $466.5M | $442.7M | $429.1M | $422.5M | $512.6M | $457.0M | $498.6M |
| Total current liabilities | $106.8M | $129.4M | $138.4M | $125.8M | $129.2M | $122.7M | $122.3M | $118.1M |
| Cash & equivalents | $110.8M | $196.5M | $163.1M | $158.1M | $132.5M | $171.7M | $115.7M | $164.2M |
| Marketable securities (current) | $186.9M | $116.9M | $133.9M | $142.7M | $168.7M | $188.0M | $208.1M | $233.3M |
| Accounts receivable | $102.1M | $81.8M | $82.4M | $66.8M | $59.9M | $70.9M | $69.3M | $55.8M |
| Inventory | $55.6M | $58.4M | $51.7M | $51.7M | $49.8M | $65.5M | $51.5M | $38.6M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $131.5M | $131.4M | $131.1M | $126.7M | $122.5M | $111.6M | $109.1M | $112.5M |
| Intangible assets | $263.9M | $269.1M | $279.3M | $285.2M | $296.3M | $285.4M | $282.4M | $306.6M |
| Other non-current assets | $6.4M | $8.3M | $8.2M | $9.3M | $10.3M | $426.0K | $369.0K | $280.0K |
| Accounts payable | $26.2M | $37.5M | $22.2M | $31.2M | $32.0M | $28.5M | $27.5M | $31.7M |
| Accrued liabilities | $78.0M | $88.1M | $111.2M | $87.3M | $89.1M | $84.7M | $81.9M | $74.8M |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $19.0K | $18.0K | $17.0K | $16.0K | $14.0K | $14.0K | $13.0K | $13.0K |
| Retained earnings | -$2.90B | -$2.85B | -$2.78B | -$2.70B | -$2.61B | -$2.50B | -$2.38B | -$2.31B |
| Accumulated other comprehensive income (loss) | $13.1M | $12.7M | $16.4M | $16.1M | $20.9M | $6.3M | -$1.0M | $16.2M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$60.8M | -$72.1M | -$52.6M | -$78.7M | -$67.4M | -$103.7M | -$73.3M | -$59.0M |
| Investing cash flow | -$74.0M | $11.4M | $775.0K | $17.0M | $13.8M | $15.9M | $23.7M | -$48.8M |
| Financing cash flow | $49.3M | $94.3M | $56.2M | $88.1M | $13.2M | $143.3M | $2.3M | $42.0M |
| Free cash flow | -$66.3M | -$78.7M | -$61.9M | -$89.5M | -$74.9M | -$109.9M | -$77.5M | -$61.3M |
| Capital expenditures | $5.4M | $6.6M | $9.3M | $10.8M | $7.5M | $6.2M | $4.2M | $2.3M |
| Depreciation & amortization | $3.8M | $2.8M | $3.7M | $3.2M | $3.4M | $2.6M | $3.3M | $5.0M |
| Share-based compensation | $11.7M | $11.3M | $38.7M | $11.9M | $14.9M | $22.9M | $62.0M | $31.0M |
| Deferred income taxes | -$1.4M | -$665.0K | $184.0K | -$2.4M | $2.0M | -$1.8M | $1.6M | -$1.5M |
| Change in accounts receivable | $20.4M | -$690.0K | $15.7M | $6.8M | -$11.0M | $1.6M | $13.6M | $24.2M |
| Change in inventory | $177.0K | $4.9M | $4.0M | $3.0M | -$6.6M | $13.8M | $18.9M | $9.9M |
| Change in accounts payable | -$11.8M | $15.9M | -$5.2M | -$4.4M | $893.0K | $2.1M | -$6.1M | $14.4M |
| Purchases of investments | $129.6M | $56.0M | $59.9M | $92.1M | $68.7M | $97.9M | $88.2M | $156.5M |
| Debt issued | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $1.2M | $4.2M | $445.0K | $466.0K | $504.0K | $5.6M | $880.0K | $6.3M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $263.5M | $164.1M | $1.2M | — | — |
| Operating income | -$403.4M | -$395.3M | -$460.6M | -$398.9M | -$342.7M |
| Net income | -$391.0M | -$372.2M | -$444.0M | -$395.9M | -$342.3M |
| EPS (diluted) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
| EPS (basic) | $-1.09 | $-1.28 | $-1.89 | $-2.49 | $-2.23 |
| Operating margin | -$153 | -$241 | -$38.7K | — | — |
| Net margin | -$148 | -$227 | -$37.3K | — | — |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $913.2M | $910.4M | $780.4M | $664.0M | $777.3M |
| Total liabilities | $214.6M | $200.0M | $195.7M | $164.3M | $155.7M |
| Stockholders' equity | $698.6M | $710.4M | $584.6M | $499.6M | $621.7M |
| Total current assets | $442.7M | $457.0M | $307.8M | $479.1M | $508.0M |
| Total current liabilities | $138.4M | $122.3M | $110.3M | $91.5M | $89.2M |
| Cash & equivalents | $163.1M | $115.7M | $114.9M | $231.7M | $78.2M |
| Marketable securities (current) | $133.9M | $208.1M | $165.0M | $240.1M | $426.2M |
| Accounts receivable | $82.4M | $69.3M | $151.0K | — | — |
| Inventory | $51.7M | $51.5M | $10.4M | — | — |
| Marketable securities (non-current) | — | — | — | — | $91.6M |
| Property, plant & equipment | $131.1M | $109.1M | $114.0M | $105.2M | $100.9M |
| Intangible assets | $279.3M | $282.4M | $229.3M | — | — |
| Other non-current assets | $8.2M | $369.0K | $270.0K | $189.0K | $1.8M |
| Accounts payable | $22.2M | $27.5M | $33.1M | $26.6M | $27.4M |
| Accrued liabilities | $111.2M | $81.9M | $69.4M | $52.3M | $56.8M |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $17.0K | $13.0K | $11.0K | $8.0K | $7.0K |
| Retained earnings | -$2.78B | -$2.38B | -$2.01B | -$1.57B | -$1.17B |
| Accumulated other comprehensive income (loss) | $16.4M | -$1.0M | $2.5M | -$902.0K | -$601.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$302.4M | -$353.0M | -$361.8M | -$292.8M | -$227.9M |
| Investing cash flow | $47.5M | -$96.4M | -$155.2M | $256.5M | $132.0K |
| Financing cash flow | $300.8M | $390.7M | $463.0M | $190.2M | $239.3M |
| Free cash flow | -$336.2M | -$364.0M | -$384.1M | -$313.2M | -$265.5M |
| Capital expenditures | $33.8M | $11.1M | $22.3M | $20.4M | $37.6M |
| Depreciation & amortization | $12.9M | $11.3M | $11.6M | $9.3M | $3.1M |
| Share-based compensation | $61.6M | $109.6M | $62.6M | $84.0M | $69.8M |
| Deferred income taxes | -$2.1M | -$2.8M | -$3.5M | — | — |
| Change in accounts receivable | $13.1M | $69.2M | $149.0K | — | — |
| Change in inventory | $14.2M | $44.4M | $10.1M | — | — |
| Change in accounts payable | -$6.7M | -$7.8M | $4.8M | $5.9M | $7.0M |
| Purchases of investments | $318.7M | $460.8M | $205.9M | $245.8M | $725.2M |
| Debt issued | — | — | — | — | $1.0M |
| Tax withholding on stock comp | $7.1M | $12.9M | $2.8M | $2.6M | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding IOVA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers52.9%
Shares Outstanding452,971,016
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 36,957,681 | $153.7M | 8.16% | +18.9% | 2026-08-07 |
| MHR FUND MANAGEMENT LLC | 28,967,103 | $120.5M | 6.39% | +0.0% | 2026-08-14 |
| State Street Corp | 24,478,268 | $101.8M | 5.40% | +40.3% | 2026-08-07 |
| TWO SIGMA INVESTMENTS, LP | 19,010,697 | $79.1M | 4.20% | +38.9% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 18,204,248 | $75.7M | 4.02% | +9.5% | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 14,388,999 | $59.9M | 3.18% | +23.0% | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 10,324,826 | $43.0M | 2.28% | +20.4% | 2026-08-12 |
| MILLENNIUM MANAGEMENT LLC | 8,525,919 | $35.5M | 1.88% | -9.4% | 2026-08-14 |
| DIMENSIONAL FUND ADVISORS LP | 6,460,449 | $26.9M | 1.43% | +144.2% | 2026-08-11 |
| Palo Alto Investors LP | 5,296,209 | $22.0M | 1.17% | -16.6% | 2026-08-14 |
| Goldman Sachs Group Inc | 5,096,334 | $21.2M | 1.13% | -41.8% | 2026-08-14 |
| Nuveen, LLC | 4,997,112 | $20.8M | 1.10% | +36.4% | 2026-08-11 |
| Bank Of America Corp /De/ | 4,993,584 | $20.8M | 1.10% | -41.2% | 2026-08-14 |
| Morgan Stanley | 4,986,461 | $20.7M | 1.10% | -19.6% | 2026-08-11 |
| JUPITER ASSET MANAGEMENT LTD | 4,535,080 | $18.9M | 1.00% | +0.0% | 2026-08-10 |
| JANE STREET GROUP, LLC | 4,393,853 | $18.3M | 0.97% | +5.3% | 2026-08-14 |
| Northern Trust Corp | 4,154,200 | $17.3M | 0.92% | +44.5% | 2026-08-12 |
| AQR CAPITAL MANAGEMENT LLC | 3,869,584 | $16.1M | 0.85% | +520.0% | 2026-08-14 |
| Wells Fargo & Company/Mn | 3,246,537 | $13.5M | 0.72% | +56.7% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,219,656 | $13.4M | 0.71% | +15.7% | 2026-08-14 |
| HRT FINANCIAL LP | 3,097,787 | $12.9K | 0.68% | -11.1% | 2026-08-14 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2,656,740 | $11.1M | 0.59% | -11.3% | 2026-08-14 |
| VANGUARD FIDUCIARY TRUST CO | 2,542,878 | $10.6M | 0.56% | +16.4% | 2026-06-30 |
| Jpmorgan Chase & Co | 2,431,616 | $10.2M | 0.54% | -2.8% | 2026-08-12 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,415,456 | $10.1K | 0.53% | -23.7% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-11 to 2026-09-08
Recent transactions
- Most recent: Vogt Frederick G (Interim CEO & General Counsel) — Option exercise of 15,626 shares on 2026-09-08.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Vogt Frederick G | Interim CEO & General Counsel | Option exercise | 2026-09-08 | 15,626 |
| BILINSKY IGOR | Chief Operating Officer | Option exercise | 2026-09-08 | 7,813 |
| Puri Raj K. | Chief Regulatory Officer | Option exercise | 2026-09-08 | 9,766 |
| Kirby Daniel Gordon | Chief Commercial Officer | Option exercise | 2026-08-10 | 10,001 |
| Roche Corleen M. | Chief Financial Officer | Option exercise | 2026-08-06 | 49,995 |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Option exercise | 2026-06-05 | 7,813 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-08 | Vogt Frederick G | Interim CEO & General Counsel | Option exercise | 15,626 | $0.00 |
| 2026-09-08 | Vogt Frederick G | Interim CEO & General Counsel | Tax withholding | 6,638 | $8.70 |
| 2026-09-08 | BILINSKY IGOR | Chief Operating Officer | Option exercise | 7,813 | $0.00 |
| 2026-09-08 | BILINSKY IGOR | Chief Operating Officer | Tax withholding | 3,976 | $8.70 |
| 2026-09-08 | Puri Raj K. | Chief Regulatory Officer | Option exercise | 9,766 | $0.00 |
| 2026-09-08 | Puri Raj K. | Chief Regulatory Officer | Tax withholding | 4,478 | $8.70 |
| 2026-09-01 | Vogt Frederick G | Interim CEO & General Counsel | Option exercise | 41,669 | $0.00 |
| 2026-09-01 | Vogt Frederick G | Interim CEO & General Counsel | Tax withholding | 17,702 | $8.28 |
| 2026-09-01 | Puri Raj K. | Chief Regulatory Officer | Option exercise | 5,470 | $0.00 |
| 2026-09-01 | Puri Raj K. | Chief Regulatory Officer | Tax withholding | 2,508 | $8.28 |
| 2026-09-01 | BILINSKY IGOR | Chief Operating Officer | Option exercise | 8,789 | $0.00 |
| 2026-09-01 | BILINSKY IGOR | Chief Operating Officer | Tax withholding | 4,472 | $8.28 |
| 2026-08-10 | Kirby Daniel Gordon | Chief Commercial Officer | Option exercise | 10,001 | $0.00 |
| 2026-08-10 | Kirby Daniel Gordon | Chief Commercial Officer | Tax withholding | 2,436 | $6.40 |
| 2026-08-06 | Roche Corleen M. | Chief Financial Officer | Option exercise | 49,995 | $0.00 |
| 2026-08-06 | Roche Corleen M. | Chief Financial Officer | Tax withholding | 21,238 | $6.21 |
| 2026-06-05 | Vogt Frederick G | Interim CEO & General Counsel | Option exercise | 15,625 | $0.00 |
| 2026-06-05 | Vogt Frederick G | Interim CEO & General Counsel | Tax withholding | 6,638 | $4.23 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Option exercise | 7,813 | $0.00 |
| 2026-06-05 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Tax withholding | 3,976 | $4.23 |
| 2026-06-05 | Puri Raj K. | Chief Regulatory Officer | Option exercise | 9,766 | $0.00 |
| 2026-06-05 | Puri Raj K. | Chief Regulatory Officer | Tax withholding | 3,843 | $4.23 |
| 2026-06-05 | BILINSKY IGOR | Chief Operating Officer | Option exercise | 7,813 | $0.00 |
| 2026-06-05 | BILINSKY IGOR | Chief Operating Officer | Tax withholding | 3,976 | $4.23 |
| 2026-06-01 | Vogt Frederick G | Interim CEO & General Counsel | Option exercise | 41,668 | $0.00 |
| 2026-06-01 | Vogt Frederick G | Interim CEO & General Counsel | Tax withholding | 17,701 | $3.96 |
| 2026-06-01 | Puri Raj K. | Chief Regulatory Officer | Option exercise | 5,469 | $0.00 |
| 2026-06-01 | Puri Raj K. | Chief Regulatory Officer | Tax withholding | 2,508 | $3.96 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Option exercise | 8,790 | $0.00 |
| 2026-06-01 | GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | Tax withholding | 4,473 | $3.96 |
| 2026-06-01 | BILINSKY IGOR | Chief Operating Officer | Option exercise | 8,790 | $0.00 |
| 2026-06-01 | BILINSKY IGOR | Chief Operating Officer | Tax withholding | 4,473 | $3.96 |
| 2026-05-11 | Kirby Daniel Gordon | Chief Commercial Officer | Option exercise | 10,000 | $0.00 |
| 2026-05-11 | Kirby Daniel Gordon | Chief Commercial Officer | Tax withholding | 2,435 | $3.70 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 01:26 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 8-K | 2026-10-05 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-09-30 | View on SEC.gov → |
| 2026-09-29 | 8-K | 2026-09-29 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-10 | 4 | 2026-09-08 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
Recent news
Headlines about IOVA (Iovance Biotherapeutics, Inc.). Links open the publisher — we don’t host full articles.
-
Iovance Biotherapeutics stock hits 52-week high at 15.32 USD
Investing.com · 2026-10-21 -
Jefferies keeps USD 20 target for Iovance Biotherapeutics stock
AD HOC NEWS · 2026-10-20 -
Iovance Biotherapeutics, Inc. (IOVA) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
IOVA Nov 2026 18.500 call (IOVA261106C00018500) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-20 -
New Cancer Data Could Be A Big Test For Iovance Biotherapeutics Stock (IOVA)
Simply Wall Street · 2026-10-20 -
IOVA Nov 2026 18.500 call (IOVA261106C00018500) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
IOVA Oct 2026 7.000 call (IOVA261023C00007000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
IOVA Oct 2026 2.500 call (IOVA261030C00002500) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-19
No headlines in this category right now — try “All”.